Oxaliplatino [Spanish]
Oxaliplatino [Spanish] Brand names, Oxaliplatino [Spanish] Analogs
Oxaliplatino [Spanish] Brand Names Mixture
- No information avaliable
Oxaliplatino [Spanish] Chemical_Formula
Oxaliplatino [Spanish] RX_link
Oxaliplatino [Spanish] fda sheet
Oxaliplatino [Spanish] msds (material safety sheet)
Oxaliplatino [Spanish] Synthesis Reference
Oxaliplatino [Spanish] Molecular Weight
Oxaliplatino [Spanish] Melting Point
Oxaliplatino [Spanish] H2O Solubility
Oxaliplatino [Spanish] State
Oxaliplatino [Spanish] LogP
Oxaliplatino [Spanish] Dosage Forms
Oxaliplatino [Spanish] Indication
Oxaliplatino [Spanish] Pharmacology
Oxaliplatino [Spanish] Absorption
Oxaliplatino [Spanish] side effects and Toxicity
Oxaliplatino [Spanish] Patient Information
Patients and patientsí caregivers should be informed of the expected side effects of ELOXATIN, particularly its neurologic effects, both the acute, reversible effects, and the persistent neurosensory toxicity. Patients should be informed that the acute neurosensory toxicity may be precipitated or exacerbated by exposure to cold or cold objects. Patients should be instructed to avoid cold drinks, use of ice, and should cover exposed skin prior to exposure to cold temperature or cold objects.
Patients must be adequately informed of the risk of low blood cell counts and instructed to contact their physician immediately should fever, particularly if associated with persistent diarrhea, or evidence of infection develop.
Patients should be instructed to contact their physician if persistent vomiting, diarrhea, signs of dehydration, cough or breathing difficulties occur, or signs of allergic reaction appear.
![Oxaliplatino_[Spanish]](/images/rx/APRD00186.gif)
